Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge

Background: Proton pump inhibitors (PPI) have reportedly been used in inappropriate clinical settings, often leading to an increased risk of adverse effects, drug interactions, and costs. Aim: The aim of this study was to evaluate the adequacy of PPI prescription in an internal medicine ward. Methods: The discharged home inpatients of a segment in the medicine department of a central hospital in the first trimester of 2017 were evaluated; those who died or were transferred to another unit were excluded. Data on gender, age, admission, and discharge therapy and diagnoses which could support PPI use were collected from clinical records. Statistical analysis was performed using Microsoft Excel 2013® and IBM SPSS Statistics 20®. Results: A total of 318 hospitalizations were included, corresponding to 301 patients; 171 (56.8%) were female and the average age was 75.4 ± 14.6 years. Among the 318 hospitalizations, 148 patients (46.5%) were on PPI at admission and 175 (55%) at discharge, the majority of them without indication (n = 91, 61.5% vs. n = 109, 62.3%). The main inappropriate indication was anticoagulation alone (n = 33, 36.3% vs. n = 43, 39.4%). There was indication for PPI therapy in 93 (29.2%) of the cases at admission and 111 (34.9%) at discharge, mostly for prophylaxis of gastrointestinal bleeding in high-risk patients (n = 82, 88.2% vs. n = 96, 86.5%). Among those with indication, 57 (61.3%) were medicated at admission versus 66 (59%) at discharge. The association between PPI therapy and an indication for its prescription was lost by the time of discharge (p = 0.245). Conclusions: PPI prescription is not in agreement with existing recommendations, which is why it should be revised at hospital discharge. The primary indication for PPI therapy is the prophylaxis of gastrointestinal bleeding in high-risk patients and the main inappropriate indication is prophylaxis in lowrisk patients. A large proportion of the patients indicated for PPI use were discharged without prescription.

Saved in:
Bibliographic Details
Main Authors: Gamelas,Verónica, Salvado,Vera, Dias,Luís
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Gastrenterologia 2019
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452019000200007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2341-45452019000200007
record_format ojs
spelling oai:scielo:S2341-454520190002000072019-08-01Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and DischargeGamelas,VerónicaSalvado,VeraDias,Luís Proton pump inhibitors Indications Overuse Prescription Background: Proton pump inhibitors (PPI) have reportedly been used in inappropriate clinical settings, often leading to an increased risk of adverse effects, drug interactions, and costs. Aim: The aim of this study was to evaluate the adequacy of PPI prescription in an internal medicine ward. Methods: The discharged home inpatients of a segment in the medicine department of a central hospital in the first trimester of 2017 were evaluated; those who died or were transferred to another unit were excluded. Data on gender, age, admission, and discharge therapy and diagnoses which could support PPI use were collected from clinical records. Statistical analysis was performed using Microsoft Excel 2013® and IBM SPSS Statistics 20®. Results: A total of 318 hospitalizations were included, corresponding to 301 patients; 171 (56.8%) were female and the average age was 75.4 ± 14.6 years. Among the 318 hospitalizations, 148 patients (46.5%) were on PPI at admission and 175 (55%) at discharge, the majority of them without indication (n = 91, 61.5% vs. n = 109, 62.3%). The main inappropriate indication was anticoagulation alone (n = 33, 36.3% vs. n = 43, 39.4%). There was indication for PPI therapy in 93 (29.2%) of the cases at admission and 111 (34.9%) at discharge, mostly for prophylaxis of gastrointestinal bleeding in high-risk patients (n = 82, 88.2% vs. n = 96, 86.5%). Among those with indication, 57 (61.3%) were medicated at admission versus 66 (59%) at discharge. The association between PPI therapy and an indication for its prescription was lost by the time of discharge (p = 0.245). Conclusions: PPI prescription is not in agreement with existing recommendations, which is why it should be revised at hospital discharge. The primary indication for PPI therapy is the prophylaxis of gastrointestinal bleeding in high-risk patients and the main inappropriate indication is prophylaxis in lowrisk patients. A large proportion of the patients indicated for PPI use were discharged without prescription.info:eu-repo/semantics/openAccessSociedade Portuguesa de GastrenterologiaGE-Portuguese Journal of Gastroenterology v.26 n.2 20192019-04-01info:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452019000200007en10.1159/000488506
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Gamelas,Verónica
Salvado,Vera
Dias,Luís
spellingShingle Gamelas,Verónica
Salvado,Vera
Dias,Luís
Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
author_facet Gamelas,Verónica
Salvado,Vera
Dias,Luís
author_sort Gamelas,Verónica
title Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
title_short Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
title_full Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
title_fullStr Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
title_full_unstemmed Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
title_sort prescription pattern of proton pump inhibitors at hospital admission and discharge
description Background: Proton pump inhibitors (PPI) have reportedly been used in inappropriate clinical settings, often leading to an increased risk of adverse effects, drug interactions, and costs. Aim: The aim of this study was to evaluate the adequacy of PPI prescription in an internal medicine ward. Methods: The discharged home inpatients of a segment in the medicine department of a central hospital in the first trimester of 2017 were evaluated; those who died or were transferred to another unit were excluded. Data on gender, age, admission, and discharge therapy and diagnoses which could support PPI use were collected from clinical records. Statistical analysis was performed using Microsoft Excel 2013® and IBM SPSS Statistics 20®. Results: A total of 318 hospitalizations were included, corresponding to 301 patients; 171 (56.8%) were female and the average age was 75.4 ± 14.6 years. Among the 318 hospitalizations, 148 patients (46.5%) were on PPI at admission and 175 (55%) at discharge, the majority of them without indication (n = 91, 61.5% vs. n = 109, 62.3%). The main inappropriate indication was anticoagulation alone (n = 33, 36.3% vs. n = 43, 39.4%). There was indication for PPI therapy in 93 (29.2%) of the cases at admission and 111 (34.9%) at discharge, mostly for prophylaxis of gastrointestinal bleeding in high-risk patients (n = 82, 88.2% vs. n = 96, 86.5%). Among those with indication, 57 (61.3%) were medicated at admission versus 66 (59%) at discharge. The association between PPI therapy and an indication for its prescription was lost by the time of discharge (p = 0.245). Conclusions: PPI prescription is not in agreement with existing recommendations, which is why it should be revised at hospital discharge. The primary indication for PPI therapy is the prophylaxis of gastrointestinal bleeding in high-risk patients and the main inappropriate indication is prophylaxis in lowrisk patients. A large proportion of the patients indicated for PPI use were discharged without prescription.
publisher Sociedade Portuguesa de Gastrenterologia
publishDate 2019
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452019000200007
work_keys_str_mv AT gamelasveronica prescriptionpatternofprotonpumpinhibitorsathospitaladmissionanddischarge
AT salvadovera prescriptionpatternofprotonpumpinhibitorsathospitaladmissionanddischarge
AT diasluis prescriptionpatternofprotonpumpinhibitorsathospitaladmissionanddischarge
_version_ 1756004319454298112